Literature DB >> 8232241

Generation of oxygen free radicals during the metabolism of cyclosporine A: a cause-effect relationship with metabolism inhibition.

F Serino1, J Grevel, K L Napoli, B D Kahan, H W Strobel.   

Abstract

A better understanding of the mechanism of lipid peroxidation during the metabolism of cyclosporine A (CsA) might help explain the toxicities of this immunosuppressive drug on various organs. Our in vitro work used microsomes prepared from livers of phenobarbital-induced male rats. The incubations (total volume 1ml) also contained a NADPH regenerating system and substrate (i.e., CsA, carbon tetrachloride, or aminopyrine) dissolved in ethanol. Lipid peroxidation was inferred from the presence of malondialdehyde (MDA) which was detected by the thiobarbituric acid assay. The formation of CsA hydroxylated metabolites (AM9 and AM1) was monitored by liquid chromatography. The activity of the microsomal incubation was confirmed by measurements of MDA and formaldehyde production caused by increasing concentrations of CsA, carbon tetrachloride, and aminopyrine. The occurrence of hydroxylated metabolites was not coupled to the production of MDA. Aminopyrine could inhibit MDA production by CsA, but CsA could not reduce the formation of formaldehyde by aminopyrine. Erythromycin, a competitor for the binding site of CsA on cytochrome P450, reduced MDA production by CsA, and CsA inhibited formaldehyde production by erythromycin. Interaction studies with SKF 525A, ketoconazole, superoxide dismutase, catalase, alpha-tocopherol, and reduced glutathione confirmed the role of cytochrome P450 and the presence of activated oxygen species as a source of microsomal peroxidation which in return may explain the inhibitory effect of CsA on cytochrome P450 itself.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232241     DOI: 10.1007/bf01076094

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Biologic significance of cyclosporine metabolites.

Authors:  B Ryffel; B M Foxwell; M J Mihatsch; P Donatsch; G Maurer
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

3.  Generation and characterization of cyclosporine metabolites produced in a hepatic microsomal system.

Authors:  F Cheung; P Y Wong; E Cole; Z Cohen; G A Levy
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

4.  Experimental cyclosporine nephrotoxicity in the rat: effect of biliary ligation and cannulation.

Authors:  S D Heys; J I Duncan; P H Whiting
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

5.  The influence of cytochrome P-450 induction on the metabolic formation of 455-NM complexes from amphetamines.

Authors:  M R Franklin
Journal:  Drug Metab Dispos       Date:  1974 May-Jun       Impact factor: 3.922

6.  Inactivation of purified rat liver cytochrome P-450 by chloramphenicol.

Authors:  J Halpert; R A Neal
Journal:  Mol Pharmacol       Date:  1980-05       Impact factor: 4.436

7.  Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver.

Authors:  J J Sheets; J I Mason
Journal:  Drug Metab Dispos       Date:  1984 Sep-Oct       Impact factor: 3.922

8.  Metabolism of cyclosporin A. I. Study in freshly isolated rabbit hepatocytes.

Authors:  G Fabre; P Bertault-Peres; I Fabre; P Maurel; S Just; J P Cano
Journal:  Drug Metab Dispos       Date:  1987 May-Jun       Impact factor: 3.922

9.  Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro.

Authors:  D J Back; P Stevenson; J F Tjia
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

10.  Serum cyclosporin levels, hepatic drug metabolism and renal tubulotoxicity.

Authors:  C Cunningham; M P Gavin; P H Whiting; M D Burke; F Macintyre; A W Thomson; J G Simpson
Journal:  Biochem Pharmacol       Date:  1984-09-15       Impact factor: 5.858

View more
  4 in total

1.  Cyclosporin A-induced free radical generation is not mediated by cytochrome P-450.

Authors:  Alexandra Krauskopf; Timo M Buetler; Nathalie S D Nguyen; Katherine Macé; Urs T Ruegg
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates.

Authors:  N Serkova; L Litt; D Leibfritz; B Hausen; R E Morris; T L James; L Z Benet; U Christians
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  Oxygen radical formation during cytochrome P450-catalyzed cyclosporine metabolism in rat and human liver microsomes at varying hydrogen ion concentrations.

Authors:  S S Ahmed; K L Napoli; H W Strobel
Journal:  Mol Cell Biochem       Date:  1995-10-18       Impact factor: 3.396

Review 4.  Role of endoplasmic reticulum stress in drug-induced toxicity.

Authors:  Fabienne Foufelle; Bernard Fromenty
Journal:  Pharmacol Res Perspect       Date:  2016-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.